Related Experiment Video
Updated: Jun 17, 2026

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
Published on: August 4, 2022
Neuroprotective properties of mildronate, a mitochondria-targeted small molecule
Jolanta Pupure1, Sergejs Isajevs, Elina Skapare
1Department of Pharmacology, Faculty of Medicine, University of Latvia, 1A Sarlotes, LV-1001, Riga, Latvia. pupure@e-apollo.lv
Abstract:
Mildronate, a representative of the aza-butyrobetaine class of drugs with proven cardioprotective efficacy, was recently found to prevent dysfunction of complex I in rat liver mitochondria. The present study demonstrates that mildronate also acts as a neuroprotective agent. In a mouse model of azidothymidine (anti-HIV drug) neurotoxicity, mildronate reduced the azidothymidine-induced alterations in mouse brain tissue: it normalized the increase in caspase-3, cellular apoptosis susceptibility protein (CAS) and iNOS expression assessed by quantitative and semi-quantitative analysis. Mildronate also normalized the changes in cytochrome c oxidase (COX) expression, reduced the expression of glial fibrillary acidic protein (GFAP) and cellular infiltration. The present results show that the neuroprotective action of mildronate results at least partially from anti-neurodegenerative (anti-apoptotic) and anti-inflammatory mechanisms. It might be suggested that the molecular conformation of mildronate can facilitate its easy binding to mitochondria, and regulate the expression of different signal molecules, hence maintaining cellular signaling and survival.
Insights
Mildronate demonstrates neuroprotective effects by reducing azidothymidine-induced brain damage in mice. This drug helps prevent cell death and inflammation, offering potential therapeutic benefits.
Area of Science:
- Neuroscience
- Pharmacology
- Mitochondrial research
Background:
- Mildronate, an aza-butyrobetaine drug, is known for cardioprotective effects.
- Previous research indicated Mildronate prevents complex I dysfunction in liver mitochondria.
Purpose of the Study:
- To investigate the neuroprotective potential of Mildronate.
- To evaluate Mildronate's effects on azidothymidine-induced neurotoxicity in a mouse model.
Main Methods:
- Utilized a mouse model of azidothymidine (anti-HIV drug) neurotoxicity.
- Assessed alterations in mouse brain tissue using quantitative and semi-quantitative analyses.
- Measured expression levels of caspase-3, CAS, iNOS, cytochrome c oxidase (COX), and glial fibrillary acidic protein (GFAP).
Main Results:
- Mildronate normalized increased caspase-3, CAS, and iNOS expression.
- It corrected changes in cytochrome c oxidase (COX) expression.
- Mildronate reduced glial fibrillary acidic protein (GFAP) expression and cellular infiltration, indicating reduced neuroinflammation.
Conclusions:
- Mildronate exhibits significant neuroprotective properties against azidothymidine-induced neurotoxicity.
- Its neuroprotection is attributed to anti-neurodegenerative (anti-apoptotic) and anti-inflammatory mechanisms.
- Mildronate's molecular structure may facilitate mitochondrial binding and regulation of signaling molecules for cellular survival.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Mitochondrial Membranes
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondria

